Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.

Liu Y, Eckenrode JM, Zhang Y, Zhang J, Hayden RC, Kyomuhangi A, Ponomareva LV, Cui Z, Rohr J, Tsodikov OV, Van Lanen SG, Shaaban KA, Leggas M, Thorson JS

Open source

DOI: 10.1021/acs.jmedchem.0c01526
Published: 2020 Nov 25
Container: Journal of medicinal chemistry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.0c01526,
  title = {Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.},
  author = {Liu Y and Eckenrode JM and Zhang Y and Zhang J and Hayden RC and Kyomuhangi A and Ponomareva LV and Cui Z and Rohr J and Tsodikov OV and Van Lanen SG and Shaaban KA and Leggas M and Thorson JS},
  year = {2020},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/acs.jmedchem.0c01526},
  url = {https://doi.org/10.1021/acs.jmedchem.0c01526}
}

RIS

TY  - JOUR
TI  - Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.
AU  - Liu Y
AU  - Eckenrode JM
AU  - Zhang Y
AU  - Zhang J
AU  - Hayden RC
AU  - Kyomuhangi A
AU  - Ponomareva LV
AU  - Cui Z
AU  - Rohr J
AU  - Tsodikov OV
AU  - Van Lanen SG
AU  - Shaaban KA
AU  - Leggas M
AU  - Thorson JS
PY  - 2020
JO  - Journal of medicinal chemistry
DO  - 10.1021/acs.jmedchem.0c01526
UR  - https://doi.org/10.1021/acs.jmedchem.0c01526
ER  -

APA

Y, L., JM, E., Y, Z., J, Z., RC, H., A, K., LV, P., Z, C., J, R., OV, T., SG, V. L., KA, S., M, L., & JS, T. (2020). Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.0c01526

Source records

pubmed · retrieved 2026-09-27T00:45:39.928Z